TotalMarketCap

Opus Genetics

IRDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$334.031 M

$4.02 -5.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Opus Genetics (IRD) has a market capitalization of $334.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$14.2M

#3060 by revenue

Earnings

-$49.6M

Loss-making

Shares outstanding

83,195,823

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #214Atea PharmaceuticalsAVIR$338.9M
  2. #215Aspen NeuroscienceASPE$335.0M
  3. #216Opus GeneticsIRD$334.0M
  4. #217Benitec BiopharmaBNTC$303.2M
  5. #218Galectin TherapeuticsGALT$301.2M

What if Opus Genetics were worth as much as…

Open the what-if tool →

Gold $28.2T

$339,402.54

Per share 84,534× higher

Bitcoin $1.53T

$18,364.48

Per share 4,574× higher

Apple $5.02T

$60,288.88

Per share 15,016× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Opus Genetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.